Published in Eur J Pharm Sci on January 01, 2005
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech (2005) 1.22
Boron polylactide nanoparticles exhibiting fluorescence and phosphorescence in aqueous medium. ACS Nano (2008) 1.20
The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells. Biomaterials (2010) 1.14
Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. J Pharm Sci (2009) 1.07
Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine (2012) 1.04
PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. Int J Nanomedicine (2012) 0.90
Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng Part A (2011) 0.89
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles. Protein Pept Lett (2014) 0.86
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A. J Transplant (2012) 0.86
Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. Biomed Res Int (2014) 0.85
Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res (2009) 0.85
Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AAPS PharmSciTech (2010) 0.85
Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres. Results Pharma Sci (2012) 0.84
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease. Int J Nanomedicine (2015) 0.81
Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis. PLoS One (2013) 0.81
Nanoparticles of polyethylene sebacate: a new biodegradable polymer. AAPS PharmSciTech (2009) 0.79
Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent. Int J Pharm (2010) 0.79
One-component nanomedicine. J Control Release (2015) 0.79
Manufacturing Techniques and Surface Engineering of Polymer Based Nanoparticles for Targeted Drug Delivery to Cancer. Nanomaterials (Basel) (2016) 0.79
Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation. Int J Nanomedicine (2015) 0.78
Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols. Eur J Pharm Sci (2011) 0.78
Nose-To-Brain Delivery of PLGA-Diazepam Nanoparticles. AAPS PharmSciTech (2015) 0.78
Poly(hydroxyalkanoates)-based polymeric nanoparticles for drug delivery. J Biomed Biotechnol (2009) 0.78
Curcumin-loaded into PLGA nanoparticles: preparation and in vitro schistosomicidal activity. Parasitol Res (2011) 0.78
Preparation and evaluation of poly (caprolactone fumarate) nanoparticles containing doxorubicin HCI. Daru (2011) 0.78
Fabrication and in vivo evaluation of Nelfinavir loaded PLGA nanoparticles for enhancing oral bioavailability and therapeutic effect. Saudi Pharm J (2015) 0.78
Preparation and characterization of selenium incorporated guar gum nanoparticle and its interaction with H9c2 cells. PLoS One (2013) 0.77
Particles from preformed polymers as carriers for drug delivery. EXCLI J (2014) 0.76
Preparation, in vitro and in vivo evaluation of mPEG-PLGA nanoparticles co-loaded with syringopicroside and hydroxytyrosol. J Mater Sci Mater Med (2015) 0.76
Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design. AAPS PharmSciTech (2014) 0.76
Polymeric Nanoparticles of Brazilian Red Propolis Extract: Preparation, Characterization, Antioxidant and Leishmanicidal Activity. Nanoscale Res Lett (2016) 0.75
Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting-Ideal Versus Reality. Pharmaceuticals (Basel) (2016) 0.75
Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization. Saudi Pharm J (2014) 0.75
Quantification of simvastatin in mice plasma by near-infrared and chemometric analysis of spectral data. Drug Des Devel Ther (2016) 0.75
Nanoprecipitation of polymeric nanoparticle micelles based on 2-methacryloyloxyethyl phosphorylcholine (MPC) with 2-(diisopropylamino)ethyl methacrylate (DPA), for intracellular delivery applications. J Mater Sci Mater Med (2015) 0.75
Preparation, Optimization, and Screening of the Effect of Processing Variables on Agar Nanospheres Loaded with Bupropion HCl by a D-Optimal Design. Biomed Res Int (2015) 0.75
Dual agents loaded polymeric nanoparticle: Effect of process variables. Int J Pharm Investig (2015) 0.75
Engineered Nanoplatelets for Enhanced Treatment of Multiple Myeloma and Thrombus. Adv Mater (2016) 0.75
Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Res Pharm Sci (2017) 0.75
Evolution of availability of curcumin inside poly-lactic-co-glycolic acid nanoparticles: impact on antioxidant and antinitrosant properties. Int J Nanomedicine (2015) 0.75
Nanoscale isoindigo-carriers: self-assembly and tunable properties. Beilstein J Nanotechnol (2017) 0.75
Facile synthesis of biocompatible gold nanoparticles from Vites vinefera and its cellular internalization against HBL-100 cells. Cancer Nanotechnol (2011) 0.75
From micro- to nanostructured implantable device for local anesthetic delivery. Int J Nanomedicine (2016) 0.75
Activity of chitosan-lysozyme nanoparticles on the growth, membrane integrity, and β-1,3-glucanase production by Aspergillus parasiticus. 3 Biotech (2017) 0.75
Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles. Front Pharmacol (2017) 0.75
State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B (2002) 2.19
Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res (2004) 1.91
Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci (2004) 1.26
Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech (2005) 1.22
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm (2002) 1.21
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur J Pharm Biopharm (2005) 1.17
Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke (2007) 1.16
Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit Rev Ther Drug Carrier Syst (2005) 1.16
Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy. Eur J Pharm Biopharm (2003) 1.13
Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan. J Vasc Interv Radiol (2010) 1.13
Dexamethasone-containing biodegradable superparamagnetic microparticles for intra-articular administration: physicochemical and magnetic properties, in vitro and in vivo drug release. Eur J Pharm Biopharm (2009) 1.13
Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials (2009) 1.06
Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjug Chem (2006) 1.04
Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl)porphyrin by incorporation into sub-200 nm nanoparticles. Eur J Pharm Sci (2003) 1.00
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia. Biomaterials (2009) 0.96
Sonication parameters for the preparation of biodegradable nanocapsules of controlled size by the double emulsion method. Pharm Dev Technol (2003) 0.92
Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. J Control Release (2009) 0.90
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting. Eur J Pharm Biopharm (2004) 0.88
In vitro sonothrombolysis of human blood clots with BR38 microbubbles. Ultrasound Med Biol (2012) 0.87
Biomaterials used in injectable implants (liquid embolics) for percutaneous filling of vascular spaces. Cardiovasc Intervent Radiol (2005) 0.86
In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound. Thromb Res (2009) 0.86
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res Ther (2009) 0.85
Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles. Eur J Pharm Sci (2005) 0.85
Co-encapsulation of dexamethasone 21-acetate and SPIONs into biodegradable polymeric microparticles designed for intra-articular delivery. J Microencapsul (2008) 0.85
Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. Eur J Pharm Sci (2005) 0.84
Cell interaction studies of PLA-MePEG nanoparticles. Int J Pharm (2003) 0.83
Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model. Int J Hyperthermia (2009) 0.81
Influence of physical parameters and lubricants on the compaction properties of granulated and non-granulated cross-linked high amylose starch. Chem Pharm Bull (Tokyo) (2002) 0.81
Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. Int J Pharm (2003) 0.79
Cardiovascular effects of selected water-miscible solvents for pharmaceutical injections and embolization materials: a comparative hemodynamic study using a sheep model. PDA J Pharm Sci Technol (2007) 0.79
Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. I. Pulse-field-gradient spin-echo NMR study of sodium salicylate diffusivity in swollen hydrogels with respect to polymer matrix physical structure. J Control Release (2008) 0.79
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for quantitation and molecular stability assessment of insulin entrapped within PLGA nanoparticles. J Pharm Sci (2005) 0.78
Intrinsically radiopaque iodine-containing polyvinyl alcohol as a liquid embolic agent: evaluation in experimental wide-necked aneurysms. J Neurosurg (2006) 0.78
Ultrasound contrast agents for brain perfusion imaging and ischemic stroke therapy. J Neuroimaging (2005) 0.77
The impact of the salting-out technique on the preparation of colloidal particulate systems for pharmaceutical applications. Recent Pat Drug Deliv Formul (2012) 0.76
Preparation of surfactant-free nanoparticles of methacrylic acid copolymers used for film coating. AAPS PharmSciTech (2006) 0.75
In 2005, the School of Pharmaceutical Sciences of the University of Geneva and Lausanne was inaugurated. Introduction. Chimia (Aarau) (2012) 0.75
Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. III. Critical use of thermodynamic parameters of activation for modeling the water penetration and drug release processes. J Control Release (2013) 0.75
Nanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogram. J Pharm Sci (2014) 0.75
Synthesis of a novel fluorescent poly(D,L-lactide) end-capped with 1-pyrenebutanol used for the preparation of nanoparticles. Eur J Pharm Sci (2003) 0.75
Characterization of binary mixtures consisting of cross-linked high amylose starch and hydroxypropylmethylcellulose used in the preparation of controlled release tablets. Pharm Dev Technol (2003) 0.75